12.11% More Trevena Inc (NASDAQ:TRVN) Shares Shorted

June 27, 2018 - By Alex Paulin

Trevena, Inc. (NASDAQ:TRVN) Corporate Logo

Trevena Inc (NASDAQ:TRVN) had an increase of its shorted shares by 12.11%. FINRA announced in June TRVN’s total 6.78M shorted shares. The 6.04 million previous shares are up with 12.11%. 11 days will cost TRVN with 622,700 average volume to recover its previous position. Trevena Inc’s shorted shares float is 13.52%.

Ticker’s shares touched $1.55 during the last trading session after 1.90% change.Trevena, Inc. has 1.04 million shares volume, 9.30% up from normal. TRVN is downtrending and has moved 39.16% since June 27, 2017. TRVN underperformed by 51.73% the S&P500.

Trevena, Inc., a biopharmaceutical company, develops various therapies based on breakthrough science to benefit patients and healthcare providers confronting serious medical conditions.The firm is valued at $112.50 million. The Company’s product candidates include oliceridine injection, a ??-receptor G protein pathway selective modulator, which is in Phase III clinical trials for the management of moderate-to-severe acute pain where intravenous administration is preferred; TRV250, a G protein biased ligand targeting the d-receptor, which is in preclinical development for the treatment of migraine; and TRV734, a small molecule G protein biased ligand at the mu-receptor that is in Phase I clinical trials for the treatment of moderate to severe acute and chronic pain, as well as TRV027 for the treatment of acute heart failure.Currently it has negative earnings.

There’s a substantial Trevena, Inc. (NASDAQ:TRVN) news posted by Globenewswire.com. It’s an article titled: “Trevena to Present at the Jefferies Global Healthcare Conference” on May 30, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.